ADVENTRX Pharmaceuticals (ANX) Reports Q3 Loss of $0.07
Get Alerts ANX Hot Sheet
Join SI Premium – FREE
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q3 EPS of ($0.07), versus ($0.13) reported last year.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- SeaStar Medical (ICU) Misses Q1 EPS by 4c
- Stantec (STN) Tops Q2 EPS by 47c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share